Status:
UNKNOWN
Quality of Life in Children Cured of Retinoblastoma
Lead Sponsor:
Hadassah Medical Organization
Collaborating Sponsors:
Israel Cancer Association
Conditions:
Retinoblastoma
Eligibility:
All Genders
1-18 years
Brief Summary
The aim of the study is to assess the quality of life of children who have been cured of retinoblastoma - a malignant eye tumor. The study is questionnaire-based, and uses standardized quality of life...
Detailed Description
Retinoblastoma is the most common eye tumor of children. It can present in one eye (unilateral) or in both eyes (bilateral). The bilateral form is always hereditary. Retinoblastoma is a highly curabl...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Past treatment for retinoblastoma
Exclusion
Key Trial Info
Start Date :
March 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2017
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00278031
Start Date
March 1 2006
End Date
December 1 2017
Last Update
October 4 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization, Jerusalem, Israel
Jerusalem, Israel, 91120